Elanco Animal Health Incorporated
ELAN
Updated: 24/09/2026, 21:32:28
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
No summaries found.
- Share price
- $22.39
- Market cap
- $11.18B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Jeffrey N. Simmons
- Employees
- 9,650
- IPO date
- 20/09/2018
- Beta
- 1.677
- Last dividend
- $0.00
- Day range
- $21.75 – $22.63
- 52-week range
- $18.48 – $27.98
- 1-day performance
- -0.82%
- 1-year performance
- 21.13%
- Current drawdown (1Y)
- -20.00%
- CIK
- 0001739104
- CUSIP
- 28414H103
- ISIN
- US28414H1032
- Created
- 07/12/2025, 03:45:22
- Last update
- 24/09/2026, 21:32:28
Track Elanco Animal Health Incorporated with an AI analyst
See which prediction-market events move ELAN, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Elanco CEO on rolling out New World screwworm vaccine: 'We're prepared'
CNBC Television • STOCK • 04/06/2026, 21:23:21
New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience
PRNewsWire • STOCK • 03/06/2026, 09:26:00
Elanco Animal Health Incorporated (ELAN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
Seeking Alpha • STOCK • 02/06/2026, 20:11:51
Elanco Animal Health Incorporated (ELAN) Presents at Stifel Jaws & Paws Conference 2026 Transcript
Seeking Alpha • STOCK • 27/05/2026, 20:27:08
Elanco Animal Health Q1 Earnings Call Highlights
MarketBeat • STOCK • 10/05/2026, 05:10:41
Elanco Animal Health Incorporated (ELAN) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 06/05/2026, 19:41:14
'WE WILL BE PREPARED': Inside efforts to stop screwworm outbreak
Fox Business • STOCK • 06/05/2026, 18:16:29
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research • STOCK • 06/05/2026, 10:45:42
Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains?
Zacks Investment Research • STOCK • 18/03/2026, 08:46:05
Elanco Animal Health Incorporated (ELAN) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
Seeking Alpha • STOCK • 17/03/2026, 16:22:18
Elanco Animal Health Incorporated (ELAN) Presents at Leerink Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 11/03/2026, 14:42:20
Elanco Animal Health Incorporated (ELAN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Seeking Alpha • STOCK • 10/03/2026, 18:50:19